Table 5

Demographic Features of Patients With Paroxysmal Supraventricular Tachycardia in Present and Previous Studies

PatientsMean Age (yr)Male/FemaleCVD Other Than WPWRecurrence Rate (%)
Calkins et al. [9]1064349/5710 (1%)N/A
Kay et al. [12]60840302/306N/AN/A
Lindsay et al. [27]594418/418 (14%)N/A
Jackman et al. [28]a804224/5614 (18%)81% at 1 mo
Chen et al. [29]40847264/14456 (14%)N/A
Rodriguez et al. [30]57436325/249N/AN/A
Wu et al. [31]1004837/636 (6%)N/A
Clair et al. [32]a1134056/5735 (31%)75% at 3 mo
Wu et al. [33]795245/3431 (39%)N/A
DiMarco et al. [34]35947186/1730N/A
Bhandari et al. [35]495015/3427 (55%)N/A
den Dulk et al. [36]404917/239 (22%)N/A
Giraudon et al. [37]32303/290N/A
Sintetos et al. [38]a344223/1110 (30%)83% at 3 mo
Henthorn et al. [39]a345011/2316 (47%)25% at 2 mo
Dorian et al. [40]1215135/86N/AN/A
Hopson et al. [41]674133/3433 (39%)N/A
Total2,863441,443/1,420(16%)71% at 3 mo
(referral centers)(females, 50%)
Present study335710/2320 (61%)6% at 3 mo,
(population based)(Females, 70%)20% at 24 mo
  • a Studies used to calculate minimal recurrence rates at 3 months. Unless otherwise indicated, data are presented as number (%) of patients. CVD = cardiovascular disease; EPS = electrophysiologic study; N/A = not available; RFA = radiofrequency ablation; WPW = Wolff-Parkinson-White syndrome.